| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-12 14:34 Tx date 2025-11-10 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$5,000
+12,500 vol $0.40 each |
87,500 | |
| Filed 2025-11-12 14:33 Tx date 2025-11-10 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,000
+25,000 vol $0.20 each |
435,000 | |
| Filed 2025-08-05 16:01 Tx date 2025-08-01 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,500
+50,000 vol $0.35 each |
400,000 | |
| Filed 2025-08-01 11:14 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+150,000 vol |
410,000 | |
| Filed 2025-08-01 11:12 Tx date 2025-07-31 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+100,000 vol |
260,000 | |
| Filed 2025-06-11 15:16 Tx date 2025-06-10 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+50,000 vol $0.40 each |
75,000 | |
| Filed 2025-06-11 15:14 Tx date 2025-06-10 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+50,000 vol $0.20 each |
160,000 | |
| Filed 2024-10-03 13:54 Tx date 2024-09-27 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,900
+10,000 vol $0.29 each |
110,000 | |
| Filed 2024-05-06 17:55 Tx date 2024-05-06 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,000
+50,000 vol $0.34 each |
100,000 | |
| Filed 2024-02-16 12:29 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Holder: 2253549 Ontario Ltd (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2024-02-16 12:28 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2024-02-06 15:29 Tx date 2024-02-02 |
$CIII
Cytophage Technologies Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Holder: 2253549 Ontario Ltd (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2024-02-06 15:20 Tx date 2024-02-02 |
$CIII
Cuspis Capital III Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2024-02-06 15:19 Tx date 2024-02-02 |
$CIII
Cuspis Capital III Ltd. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2022-11-15 17:14 Tx date 2022-09-19 |
$IAN
iAnthus Capital Holdings, Inc. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,872
+3,938,678 vol $0.051 each |
3,938,678 | |
| Filed 2022-11-15 14:37 Tx date 2022-06-24 |
$IAN
iAnthus Capital Holdings, Inc. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-257,750 vol |
0 | |
| Filed 2022-11-15 14:35 Tx date 2022-10-03 |
$IAN
iAnthus Capital Holdings, Inc. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+19,379,105 vol |
19,794,387 | |
| Filed 2022-11-15 14:33 Tx date 2022-10-03 |
$IAN
iAnthus Capital Holdings, Inc. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
57 - Exercise of rights
|
-23,632,068 vol |
11,816,034 | |
| Filed 2022-11-15 14:28 Tx date 2022-06-24 |
$IAN
iAnthus Capital Holdings, Inc. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,344,272 vol |
0 | |
| Filed 2022-11-15 14:27 Tx date 2022-06-26 |
$IAN
iAnthus Capital Holdings, Inc. |
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,344,272 vol |